Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Apr;19(4):328-332.e2.
doi: 10.1016/j.jamda.2017.09.015. Epub 2017 Nov 7.

Age, Sex, and Dose Effects of Nonbenzodiazepine Hypnotics on Hip Fracture in Nursing Home Residents

David D Dore  1 , Andrew R Zullo  2 , Vincent Mor  3 , Yoojin Lee  3 , Sarah D Berry  4
Affiliations

Age, Sex, and Dose Effects of Nonbenzodiazepine Hypnotics on Hip Fracture in Nursing Home Residents

David D Dore et al. J Am Med Dir Assoc. 2018 Apr.

Abstract

Objective: The Food and Drug Administration recommends a reduced dose of nonbenzodiazepine hypnotics in women, yet little is known about the age-, sex-, and dose-specific effects of these drugs on risk of hip fracture, especially among nursing home (NH) residents. We estimated the age-, sex-, and dose-specific effects of nonbenzodiazepine hypnotics on the rate of hip fracture among NH residents.

Design and setting: Case-crossover study in US NHs.

Participants: A total of 691 women and 179 men with hip fracture sampled from all US long-stay NH residents.

Measurements: Measures of patient characteristics were obtained from linked Medicare and the Minimum Data Set (2007-2008). The outcome was hospitalization for hip fracture with surgical repair. We estimated rate ratios (RRs) and 95% confidence intervals (CIs) from conditional logistic regression models for nonbenzodiazepine hypnotics (vs nonuse) comparing 0 to 29 days before hip fracture (hazard period) with 60 to 89 and 120 to 149 days before hip fracture (control periods). We stratified analyses by age, sex, and dose.

Results: The average RR of hip fracture was 1.7 (95% CI 1.5-1.9) for any use. The RR of hip fracture was higher for residents aged ≥90 years vs <70 years (2.2 vs 1.3); however, the CIs overlapped. No differences in the effect of the hypnotic on risk of hip fracture were evident by sex. Point estimates for hip fracture were greater with high-dose versus low-dose hypnotics (RR 1.9 vs 1.6 for any use), but these differences were highly compatible with chance.

Conclusions: The rate of hip fracture in NH residents due to use of nonbenzodiazepine hypnotics was greater among older patients than among younger patients and, possibly, with higher doses than with lower doses. When clinicians are prescribing a nonbenzodiazepine hypnotic to any NH resident, doses of these drugs should be kept as low as possible, especially among those with advanced age.

Keywords: Nonbenzodiazepine hypnotics; case-crossover study; hip fracture; nursing home; pharmacoepidemiology.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Relative Rate of Non-benzodiazepine Hypnotic Use on the Occurrence of Hip Fracture Relative to Non-use among US Long-stay Nursing Home Residents, 2007–2008.
See this image and copyright information in PMC

References

    1. U.S. Food and Drug Administration. [Accessed February 3, 2013];Drug Safety Communication: Risk of next - morning impairment after use of insomnia drugs; FDA requires lower recommended doses for certain drugs containing zolpidem (Ambien, Ambien CR, Edluar, and Zolpimist) 2013 http://www.fda.gov/Drugs/DrugSafety/ucm334033.htm.
    1. Bocca ML, Marie S, Lelong-Boulouard V, Bertran F, et al. Zolpidem and zopiclone impair similarly monotonous driving performance after a single nighttime intake in aged subjects. Psychopharmacology. 2011;214(3):699–706. - PubMed
    1. Leufkens TR, Lund JS, Vermeeren A. Highway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidem. Journal of sleep research. 2009;18(4):387–396. - PubMed
    1. Verster JC, Roth T. Gender differences in highway driving performance after administration of sleep medication: a review of the literature. Traffic injury prevention. 2012;13(3):286–292. - PubMed
    1. Greenblatt DJ, Harmatz JS, von Moltke LL, Wright CE, et al. Age and gender effects on the pharmacokinetics and pharmacodynamics of triazolam, a cytochrome P450 3A substrate. Clinical pharmacology and therapeutics. 2004;76(5):467–479. - PubMed

Publication types

MeSH terms

Substances